Teva Pharmaceutical Industries Ltd (TEVA)
13.98
-0.10
(-0.71%)
USD |
NYSE |
May 03, 16:00
14.04
+0.06
(+0.43%)
After-Hours: 20:00
Teva Pharmaceutical Industries Price to Book Value: 2.088 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.088 |
| May 02, 2024 | 2.103 |
| May 01, 2024 | 2.088 |
| April 30, 2024 | 2.098 |
| April 29, 2024 | 2.106 |
| April 26, 2024 | 2.063 |
| April 25, 2024 | 1.979 |
| April 24, 2024 | 1.943 |
| April 23, 2024 | 1.943 |
| April 22, 2024 | 1.924 |
| April 19, 2024 | 1.921 |
| April 18, 2024 | 1.909 |
| April 17, 2024 | 1.969 |
| April 16, 2024 | 1.955 |
| April 15, 2024 | 1.976 |
| April 12, 2024 | 1.986 |
| April 11, 2024 | 2.072 |
| April 10, 2024 | 2.069 |
| April 09, 2024 | 2.087 |
| April 08, 2024 | 2.121 |
| April 05, 2024 | 2.128 |
| April 04, 2024 | 2.081 |
| April 03, 2024 | 2.109 |
| April 02, 2024 | 2.070 |
| April 01, 2024 | 2.078 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.108 |
| March 27, 2024 | 2.155 |
| March 26, 2024 | 2.112 |
| March 25, 2024 | 2.10 |
| March 22, 2024 | 2.075 |
| March 21, 2024 | 2.054 |
| March 20, 2024 | 2.013 |
| March 19, 2024 | 1.994 |
| March 18, 2024 | 1.990 |
| March 15, 2024 | 2.006 |
| March 14, 2024 | 2.016 |
| March 13, 2024 | 2.039 |
| March 12, 2024 | 2.015 |
| March 11, 2024 | 1.994 |
| March 08, 2024 | 2.034 |
| March 07, 2024 | 2.048 |
| March 06, 2024 | 2.021 |
| March 05, 2024 | 2.022 |
| March 04, 2024 | 2.007 |
| March 01, 2024 | 2.016 |
| February 29, 2024 | 1.964 |
| February 28, 2024 | 1.955 |
| February 27, 2024 | 1.986 |
| February 26, 2024 | 1.985 |
| February 23, 2024 | 1.925 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4763
Minimum
Aug 15 2019
2.155
Maximum
Mar 27 2024
1.105
Average
1.064
Median
Apr 28 2022
Price to Book Value Benchmarks
| Viatris Inc | 0.6835 |
| Alvotech | -- |
| AstraZeneca PLC | 6.322 |
| Corcept Therapeutics Inc | 5.009 |
| GSK PLC | 5.076 |
Price to Book Value Related Metrics
| PS Ratio | 0.9901 |
| Price to Free Cash Flow | 18.63 |
| Price | 13.98 |
| Earnings Yield | -3.36% |
| Market Cap | 15.67B |
| Operating PE Ratio | 4.915 |
| Normalized PE Ratio | 8.657 |